Isofol Medical AB (publ) announced that Thomas Andersson, at his own request, has chosen to resign as Chief Executive Officer of the company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.677 SEK | -2.45% | -5.84% | -7.26% |
Feb. 20 | Isofol Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Feb. 20 | Isofol Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-7.26% | 10.22M | |
+4.20% | 70.44B | |
+10.97% | 8.94B | |
-16.83% | 4.75B | |
+43.48% | 4.5B | |
+3.20% | 3.85B | |
-21.36% | 2.34B | |
-29.67% | 2.2B | |
+8.38% | 1.96B | |
+3.90% | 1.65B |
- Stock Market
- Equities
- ISOFOL Stock
- News Isofol Medical AB
- Isofol Medical AB Announces Resignation of Thomas Andersson as CEO